|
EXTL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.13467046658889E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.28709995386822E-09 |
| Normal-vs-Stage2 |
9.19029999990606E-07 |
| Normal-vs-Stage3 |
3.59410279315853E-11 |
| Normal-vs-Stage4 |
1.209199962382E-09 |
| Stage1-vs-Stage2 |
9.292600E-01 |
| Stage1-vs-Stage3 |
1.509020E-01 |
| Stage1-vs-Stage4 |
7.305600E-02 |
| Stage2-vs-Stage3 |
2.410600E-01 |
| Stage2-vs-Stage4 |
9.635600E-02 |
| Stage3-vs-Stage4 |
4.694600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.90083537588271E-13 |
| Normal-vs-AfricanAmerican |
2.227800E-04 |
| Normal-vs-Asian |
5.7161999999944E-05 |
| Caucasian-vs-AfricanAmerican |
4.329400E-01 |
| Caucasian-vs-Asian |
1.466170E-01 |
| AfricanAmerican-vs-Asian |
7.877800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.21599968877706E-10 |
| Normal-vs-Female |
2.86020096496031E-11 |
| Male-vs-Female |
7.043200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.96150004519546E-09 |
| Normal-vs-Age(41-60Yrs) |
4.02540001331886E-10 |
| Normal-vs-Age(61-80Yrs) |
7.44969974597609E-10 |
| Normal-vs-Age(81-100Yrs) |
2.637300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.935000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.386400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.317800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.532200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.692000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.578200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.993930E-04 |
| Classical-VS-Follicular |
2.940000E-01 |
| Classical-VS-Other |
5.545400E-01 |
| Classical-VS-Normal |
9.16150488805556E-11 |
| Tall-VS-Follicular |
1.424850E-04 |
| Tall-VS-Other |
2.712000E-01 |
| Tall-VS-Normal |
3.99347221957669E-12 |
| Follicular-VS-Other |
4.088800E-01 |
| Follicular-VS-Normal |
3.71610000000633E-05 |
| Other-VS-Normal |
4.860400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.25429999719984E-09 |
| Normal-vs-N1 |
6.09159944708892E-10 |
| N0-vs-N1 |
1.335590E-01 |
|
|
